We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$4.78B
AUM Growth
+$300M
Cap. Flow
-$1.75M
Cap. Flow %
-0.04%
Top 10 Hldgs %
35.41%
Holding
646
New
42
Increased
82
Reduced
148
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 22.82%
2 Healthcare 17.92%
3 Consumer Staples 12.87%
4 Consumer Discretionary 9.99%
5 Industrials 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WASH icon
551
Washington Trust Bancorp
WASH
$750M
$10K ﹤0.01%
200
BPY
552
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$10K ﹤0.01%
445
WPG
553
DELISTED
Washington Prime Group Inc.
WPG
$10K ﹤0.01%
128
SPLS
554
DELISTED
Staples Inc
SPLS
$10K ﹤0.01%
1,150
EVV
555
Eaton Vance Limited Duration Income Fund
EVV
$1.08B
$9K ﹤0.01%
666
GFI icon
556
Gold Fields
GFI
$36.4B
$9K ﹤0.01%
2,500
KEYS icon
557
Keysight
KEYS
$60.6B
$9K ﹤0.01%
257
VMW
558
DELISTED
VMware, Inc
VMW
$9K ﹤0.01%
100
XLRN
559
DELISTED
Acceleron Pharma
XLRN
$9K ﹤0.01%
337
BATRK icon
560
Atlanta Braves Holdings Series B
BATRK
$3.4B
$8K ﹤0.01%
355
-182
-34% -$3.89K
CVE icon
561
Cenovus Energy
CVE
$55.6B
$8K ﹤0.01%
725
EFOI icon
562
Energy Focus
EFOI
$19.2M
$8K ﹤0.01%
+71
New +$10.1K
FBIN icon
563
Fortune Brands Innovations
FBIN
$5.83B
$8K ﹤0.01%
154
LEE icon
564
Lee Enterprises
LEE
$182M
$8K ﹤0.01%
300
AMJ
565
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$8K ﹤0.01%
250
BBBY
566
DELISTED
Bed Bath & Beyond Inc
BBBY
$8K ﹤0.01%
200
ATHN
567
DELISTED
Athenahealth, Inc.
ATHN
$8K ﹤0.01%
70
-63
-47% -$7.34K
AVNS
568
DELISTED
Avanos Medical
AVNS
$7K ﹤0.01%
189
-137
-42% -$5.34K
BCX icon
569
BlackRock Resources & Commodities Strategy Trust
BCX
$965M
$7K ﹤0.01%
818
CLX icon
570
Clorox
CLX
$12.8B
$7K ﹤0.01%
55
JAZZ icon
571
Jazz Pharmaceuticals
JAZZ
$16.2B
$7K ﹤0.01%
50
WLY icon
572
John Wiley & Sons Class A
WLY
$2.53B
$7K ﹤0.01%
135
GWPH
573
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$7K ﹤0.01%
60
MNK
574
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$7K ﹤0.01%
146
AN icon
575
AutoNation
AN
$6.9B
$6K ﹤0.01%
150

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Loring Wolcott & Coolidge Fiduciary Advisors held 646 positions worth $4.78B, up 6.7% from $4.49B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2017 filing shows 42 new, 82 increased, 148 reduced and 23 closed positions. Its largest new stake was Bioverativ Inc. Common Stock: 4,241 shares worth $231K. The largest sale was Praxair Inc, an estimated $44.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 4,241 shares worth $231K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Occidental Petroleum in Q1 2017, an estimated $17.1M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q1 2017 reduction was Praxair Inc, cutting an estimated $44.3M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Linear Technology Corp in Q1 2017, selling an estimated $6.42M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 35% of its $4.78B portfolio in Q1 2017.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 42 new positions and closed 23 in Q1 2017.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 6.7% quarter-over-quarter to $4.78B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2017, filed 15 May 2017.